Sonic Fund II

Latest statistics and disclosures from Sonic Fund II's latest quarterly 13F-HR filing:

  • Sonic Fund II was a net seller of stock by $0.

Portfolio Holdings for Sonic Fund II

Companies in the Sonic Fund II portfolio as of the December 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Adverum Biotechnologies 47.83 4.04M 11.52
Regenxbio Inc equity us cm 19.59 465664 40.97
Sarepta Therapeutics 14.93 112689 129.04
Genworth Financial (GNW) 9.48 2.10M 4.40
Fennec Pharmaceuticals Inc 5.56 834689 6.49
Third Point Reinsurance 2.45 227185 10.52
Tronox Holdings Plc shs 0.15 13055 11.41